Author:
Eppenberger U.,Löser R.,Küng W.,Roos W.
Reference8 articles.
1. Smith IE, Harris AL, Morgan M, Ford HT, Gazel JC, Harmer CL, White H, Parsons CA, Villardo A, Walsh G, McKinna JA (1981): Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Br Med J 283: 1432–1434.
2. McGuire WL, Zava DT, Horwitz KB, Chamness G (1978): Steroid receptors in breast tumours: Current status. Curr Top Exp Endocrinol 3, 93–129.
3. Lippman ME, Bolan G, Hiff K (1976): The effect of estrogens and anti- estrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595–4601.
4. Rorke EA, Katzenellenbogen BS (1981): Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7.12-dimethylbenz(a)anthracene-induced rat mammary tumor system. Cancer Res (41): 1257–1262.
5. Horwitz KB, McGuire WL (1978): Antiestrogens, mechanism of action and effects in breast cancer. In: McGuire WL (ed) Breast cancer: Advances in research and treatment. Vol. 2, New York: Plenum Publishing Corp. 22 155–204.